A polymerase chain reaction-restriction fragment length polymorphism method for screening ZNF804A gene polymorphism (rs1344706) in patients with schizophrenia: A significant association

7Citations
Citations of this article
28Readers
Mendeley users who have this article in their library.
Get full text

Abstract

The original ZNF804A rs1344706 risk variant was identified through genome-wide association studies as a risk factor for schizophrenia. Follow-up studies involving meta-analysis have confirmed that rs1344706 is a risk factor for schizophrenia as well as bipolar disorders. We describe here a polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method to genotype ZNF804A rs1344706 variant in patients with schizophrenia. We generated a 220bp fragment through PCR and subsequently cleaved it by the restriction endonuclease BsaBI, creating two fragments of 114 and 106bp. Upon change in the nucleotide from T to G, the 106bp fragment is further cleaved by BsaBI, thus creating two fragments of 87 and 19bp. As a result, when the 220bp fragment is cleaved by BsaBI restriction endonuclease, the TT genotype yields two fragments of 114 and 106bp, and TG genotype four fragments of 114, 106, 87, and 19bp, and the GG genotype three fragments of 114, 87, and 19bp. Thus, this is a simple, fast, and cost-effective method to genotype the ZNF804A rs1344706 risk variant. Using this method, we were able to replicate an association between ZNF804A rs1344706 variant and schizophrenia in a Turkish population. Stratification analysis of the population according to the gender showed an association that was statistically significant among overall schizophrenia and male schizophrenia and the risk T allele and TT genotype of the ZNF804A gene. © Copyright 2012, Mary Ann Liebert, Inc..

Cite

CITATION STYLE

APA

Sazci, A., Ozel, M. D., Ergul, E., & Yildiz, M. (2012). A polymerase chain reaction-restriction fragment length polymorphism method for screening ZNF804A gene polymorphism (rs1344706) in patients with schizophrenia: A significant association. Genetic Testing and Molecular Biomarkers, 16(3), 157–161. https://doi.org/10.1089/gtmb.2011.0142

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free